-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – REC-4881 in Solid Tumor
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.REC-4881 in Solid Tumor Drug Details: REC-4881 is under development for the treatment of familial adenomatous...
-
Product Insights
Gomo (REC-T-183/197) Field, Brazil
Gomo (REC-T-183/197) upstream field is located in Bahia, Brazil. The upstream field is owned by Alvopetro SA Extracao de Petroleo e Gas Natural. It is operated by Alvopetro SA Extracao de Petroleo e Gas Natural. The project started its operations in 2022. Gomo (REC-T-183/197) Upstream Field profile includes core details such as name, resource type, asset status, stage, owner and equity stakes, operator, product specs (gravity, CO2, sulphur), location, as well as key operational data including production, start and end...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – REC-4881 in Familial Adenomatous Polyposis
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. REC-4881 in Familial Adenomatous Polyposis Drug Details: REC-4881 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – REC-2282 in Neurofibromatoses Type II
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.REC-2282 in Neurofibromatoses Type IIDrug Details:REC-2282 is under development for the treatment of relapsed or refractory...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – REC-163964 in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. REC-163964 in Clostridioides difficile Infections (Clostridium difficile Associated Disease) Drug Details: REC-163964 is under...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – REC-994 in Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hemangioma)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data.REC-994 in Cavernous Hemangioma (Cerebral Cavernous Malformation/Cerebral Cavernous Hemangioma)Drug Details:REC-0000994 (Tempol) is under development for the...
-
Product Insights
China REC/ TITIJYA – The Shore Kota Kinabalu – Sabah
Equip yourself with the essential tools needed to make informed and profitable decisions with our China REC/ TITIJYA - The Shore Kota Kinabalu - Sabah report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
Lambeth City – Growing Brixton’s Rec Quarter – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our Lambeth City - Growing BrixtonÂ’s Rec Quarter - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story: Dive deep...
-
Product Insights
SUEZ Recylg and Rec UK – Darwen Anaerobic Digestion Plant – Lancashire
Equip yourself with the essential tools needed to make informed and profitable decisions with our SUEZ Recylg and Rec UK - Darwen Anaerobic Digestion Plant - Lancashire report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash the full story:...
-
Product Insights
SUEZ Recylg and Rec UK – Benedict Wharf Waste Site Residential Community – Greater London
Equip yourself with the essential tools needed to make informed and profitable decisions with our SUEZ Recylg and Rec UK - Benedict Wharf Waste Site Residential Community - Greater London report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report? Unleash...
-
Product Insights
BP/ SUEZ Recylg and Rec UK – Net Zero Teesside Carbon Capture Storage Facility – Middlesbrough
Equip yourself with the essential tools needed to make informed and profitable decisions with our BP/ SUEZ Recylg and Rec UK - Net Zero Teesside Carbon Capture Storage Facility - Middlesbrough report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose our report?...
-
Product Insights
Charleston Park & Rec/ Mount Pleasant City – Rifle Range Road Park and Sports Complex – South Carolina
Equip yourself with the essential tools needed to make informed and profitable decisions with our Charleston Park & Rec/ Mount Pleasant City - Rifle Range Road Park and Sports Complex - South Carolina report./b> Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 business days of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Why choose...
-
Company Profile
![]()
REC Ltd – Company Profile
REC Ltd (REC), a subsidiary of Power Finance Corp Ltd is a financial company. It engages in providing financial assistance to state power utilities, private sector project developers, central power sector utilities and state governments for rural electrification projects. The company also provides financial products such as short term loans, medium term loans, debt refinancing, equity financing and long term loans for the development of various segments of power infrastructure, transmission and power distribution. It offers both conventional and renewable...
Add to Basket -
Company Profile
![]()
REC Silicon ASA – Company Profile
REC Silicon ASA (REC Silicon), formerly Renewable Energy Corporation ASA, is a producer of advanced silicon materials and delivers high-purity polysilicon and silicon gas. Its products find application in the solar and electronics industries in the production of solar panels and flat panel displays. REC Silicon caters its products to the solar and electronics industries. The company operates manufacturing facilities in Moses Lake, Washington and Butte, Montana in the US. REC Silicon has an operational presence in Asia-Pacific, Europe, North...
Add to Basket -
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Propranolol Hydrochloride in Retinopathy Of Prematurity
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Propranolol Hydrochloride in Retinopathy Of Prematurity Drug Details:Propranolol hydrochloride (REC-0551) is under development for the treatment...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Dutogliptin Tartrate in Post-Myocardial Infarction
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Dutogliptin Tartrate in Post-Myocardial Infarction Drug Details: Dutogliptin tartrate (REC-01) is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – BDB-018 in Solid Tumor
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. BDB-018 in Solid Tumor Drug Details: BDB-018 is under development for the treatment of...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Apomorphine in Parkinson’s Disease
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Apomorphine in Parkinson's Disease Drug Details:Staccato apomorphine is under development for the treatment of Parkinson's disease....
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – ZL-1211 in Adenocarcinoma Of The Gastroesophageal Junction
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. ZL-1211 in Adenocarcinoma Of The Gastroesophageal Junction Drug Details: ZL-1211 is under development for...
-
Product Insights
New![]()
Likelihood of Approval and Phase Transition Success Rate Model – Branebrutinib in Rheumatoid Arthritis
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Branebrutinib in Rheumatoid Arthritis Drug Details:Branebrutinib (BMS-986195) is under development for the treatment of moderate to...
Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.